Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- 14 Active Ingredients Included in NHI Price List
June 18, 2001
- Takeda Discovers Metastasis Suppressor Peptide Ligand
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
June 18, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIE -1-
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
June 18, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 18, 2001
- Patient-Oriented Healthcare Discussed: JPMA Seminar
June 18, 2001
- REGULATORY NEWS IN BRIEF
June 18, 2001
- Taxol Approved for Gastric Cancer
June 18, 2001
- All Parties Should Cooperate to Establish Desirable Trade Practices: EAD Director
June 18, 2001
- DIAGNOSTIC NEWS IN BRIEF
June 18, 2001
- Drug Safety Measures by Korosho Must Meet Int'l Standards: PMSB
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
June 11, 2001
- Sankyo's Olmesartan More Effective than Other ARBs: Study
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
June 11, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
June 11, 2001
- Proposed Drug Classification Gives Top Priority to Clinical Usage
June 11, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -4-
June 11, 2001
- Implementation Working Group Formed for Coordinated Application of CTD
June 11, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…